Filter
5630
Text search:
drug
development
Featured
Recommendations
499
New Publications
1473
Language
Document type
No document type
3317
Studies & Reports
912
Guidelines
720
Manuals
257
Strategic & Response Plan
183
Fact sheets
86
Training Material
82
Situation Updates
22
Infographics
14
Resource Platforms
12
Brochures
10
Online Courses
5
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
316
Global
207
Kenya
177
South Africa
134
Ethiopia
132
Uganda
131
Nigeria
119
Western and Central Europe
110
Tanzania
106
Nepal
101
Sierra Leone
92
Zambia
90
Liberia
89
Malawi
85
Africa
83
Myanmar / Burma
80
Latin America and the Carribbean
77
Ghana
75
Bangladesh
72
Rwanda
66
Namibia
61
Eastern Europe
58
Ukraine
57
Philippines
52
Asia
45
Zimbabwe
44
Cambodia
40
South–East Asia Region
40
Russia
38
Lesotho
37
Indonesia
31
Botswana
30
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Germany
19
Colombia
19
Brazil
18
East and Southern Africa
18
South Sudan
17
Cameroon
16
Haiti
15
West and Central Africa
15
USA
14
Middle East and North Africa
14
Tajikistan
13
Thailand
12
Venezuela
12
Albania
12
Pakistan
11
China
11
Vietnam
11
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Georgia
9
Sudan
8
Argentina
8
Sri Lanka
7
Paraguay
7
Armenia
7
Laos
7
Moldova
7
Mexico
6
Yemen
6
Western Pacific Region
6
North America
6
Iraq
5
Lebanon
5
Benin
5
Central African Republic
5
Peru
5
North Macedonia
5
El Salvador
5
Mali
4
Somalia
4
Jordan
4
Bhutan
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Turkey
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Libya
3
Angola
3
Madagascar
3
Fiji
3
Palestine
3
Kyrgyzstan
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Ecuador
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Estonia
2
Uzbekistan
2
Kazakhstan
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Greece
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Australia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2192
Clinical Guidelines
477
Public Health
271
Women & Child Health
216
Key Resources
159
Capacity Building
87
Pharmacy & Technologies
67
Annual Report MEDBOX
1
Toolboxes
HIV
674
Mental Health
551
TB
533
AMR
287
NTDs
244
COVID-19
207
Pharmacy
160
NCDs
119
Caregiver
111
Malaria
103
Ebola & Marburg
80
Planetary Health
78
Refugee
70
Disability
65
Rapid Response
65
Global Health Education
63
Conflict
58
Health Financing Toolbox
55
2.0 Rapid Response
28
Polio
22
Natural Hazards
20
Zika
17
Cholera
16
Specific Hazards
16
Social Ethics
15
2nd revised edition. Accessed Apri. 17, 2019
Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar
...
ournal of Public Health in Africa 2021; volume 12:2009
A new formulation of a drug to prevent excessive bleeding following childbirth could save thousands of women’s lives in low- and lower-middle-income countries, according to a study led by the World Health Organization (WHO) in collaboration with M
...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health
...
World Psychiatry16:2 - June 2017
First published: 12 May 2017
https://doi.org/10.1002/wps.20428
Volume16, Issue2; Pages 213-214
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
Strategic Overview
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
Psychoactive substance use affects the functioning of the brain and leads to impaired driving
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also re
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...